Sign up for our Oncology Central weekly news round-up

About Oncology Central

Oncology Central, part of Taylor Francis, is a free online platform that is dedicated to advancing oncology by offering access to trusted, engaging and insightful resources – including breaking news, peer-reviewed articles, webinars and articles from key opinion leaders.

By providing 360° perspectives on the latest advancements – encompassing the viewpoints of industry, clinicians, researchers, charities and patients alike – we are very proud to have established Oncology Central as a key resource for the global oncology community.

About Taylor & Francis

Taylor & Francis supports diverse communities of experts, researchers and knowledge makers around the world to accelerate and maximize the impact of their work. We are a leader in our field, publish across all disciplines and have one of the largest Humanities and Social Sciences portfolios. Our expertise, built on an academic publishing heritage of over 200 years, advances trusted knowledge that fosters human progress.

Our 2,500+ people, based in a global network of offices in more than 15 countries, use their skills and the latest technology to curate, validate and share impactful advanced, emergent and applied knowledge. Under the Taylor & Francis, Routledge and F1000 imprints we publish 2,700 journals, 8,000 new books each year and partner with more than 700 scholarly societies.

Taylor & Francis is proud to be a Global Certified Accessible™ publisher and our operations and all our print publications are certified CarbonNeutral®.

The people behind Oncology Central

Meet the team
Jade Parker
Senior Editor
Rachel Jenkins
Head of Publishing Solutions
Roshaine Wijayatunga
Managing Commissioning Editor, Future Oncology
Leela Ripton
Head of Digital and Marketing